TCM
TXG icon

TimesSquare Capital Management’s 10x Genomics TXG Stock Holding History

TimesSquare Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,670
Closed -$701K – 170
2024
Q1 		$701K Buy
+18,670
New +$820K 0.01% 161

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TimesSquare Capital Management's TXG Position: Q2 2024 in Review

TimesSquare Capital Management sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 18,670 shares — an estimated $701K sold.

TimesSquare Capital Management first reported a position in TXG in Q1 2024 and held it in 1 quarter. The position peaked at $701K in Q1 2024. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • TimesSquare Capital Management reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • TimesSquare Capital Management sold 18,670 10x Genomics shares in Q2 2024, an estimated $701K.
  • TimesSquare Capital Management first reported a position in 10x Genomics in Q1 2024 and held it in 1 quarter.
  • TimesSquare Capital Management's 10x Genomics position peaked at $701K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on TimesSquare Capital Management's 13F filing for Q2 2024, filed 8 Aug 2024.